These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26099726)

  • 1. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
    Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
    Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
    Kumari A; Bahl C; Singh N; Behera D; Sharma S
    Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
    Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
    World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
    Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
    Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region.
    Brant O; Hoffmann M; Kanappilly A; Görögh T; Gottschlich S
    Anticancer Res; 2007; 27(5A):3301-5. PubMed ID: 17970074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNP rs1049430 in the 3'-UTR of SH3GL2 regulates its expression: Clinical and prognostic implications in head and neck squamous cell carcinoma.
    Maiti GP; Ghosh A; Mondal P; Baral A; Datta S; Samadder S; Nayak SP; Chakrabarti J; Biswas J; Sikdar N; Chowdhury S; Roy B; Roychowdhury S; Panda CK
    Biochim Biophys Acta; 2015 May; 1852(5):1059-67. PubMed ID: 25728707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 (CDKN2A) SNP rs11515 was not associated with head and neck carcinoma.
    Pinheiro UB; de Carvalho Fraga CA; Mendes DC; Marques-Silva L; Farias LC; de Souza MG; Soares MB; Jones KM; Santos SH; de Paula AM; Velásquez-Meléndez G; Guimarães AL
    Tumour Biol; 2014 Jun; 35(6):6113-8. PubMed ID: 24633888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 codon 72 polymorphism association with head and neck squamous cell carcinoma.
    Mojtahedi Z; Hashemi SB; Khademi B; Karimi M; Haghshenas MR; Fattahi MJ; Ghaderi A
    Braz J Otorhinolaryngol; 2010; 76(3):316-20. PubMed ID: 20658010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
    Hori Y; Miyabe K; Yoshida M; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Umemura S; Kato A; Ohara H; Inagaki H; Joh T
    PLoS One; 2015; 10(3):e0118829. PubMed ID: 25734904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of TP53 and MDM2 genotypes and clinical outcome in platinum-treated head and neck cancer patients with more than 10 years' follow-up.
    Vivenza D; Monteverde M; Lattanzio L; Tonissi F; Astesana V; Denaro N; Comino A; Russi E; Lo Nigro C; Merlano M
    Int J Biol Markers; 2016 May; 31(2):e183-92. PubMed ID: 26916894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 15. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients.
    Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP
    Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
    Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
    Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
    Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
    Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
    El Baroudi M; Machiels JP; Schmitz S
    Cancer Biol Ther; 2017 Oct; 18(10):775-782. PubMed ID: 28886272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between the Trp53 codon 72 polymorphism and head and neck cancer: a case-control study in a South Indian population.
    Suresh K; Chandirasekar R; Kumar BL; Venkatesan R; Sasikala K
    Asian Pac J Cancer Prev; 2010; 11(6):1749-53. PubMed ID: 21338227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.